News from the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria
Scientists at CeMM and the Medical University of Vienna shed light at a complex immune program that starts right after birth: the study published in Cell Reports reveals how interleukin-33 signaling induced by the first breath shapes the performance of pulmonary immune cells and influences anti-bacterial defenses.
Community News from the Institute for Molecular Medicine Finland (FIMM), Finland
The recently established EV Core at the University of Helsinki is a globally unique technology core providing extracellular vesicle (EV) know-how and tools for characterization and downstream analyses of EVs.
Community News from the Max Delbrück Center for Molecular Medicine (MDC), Germany
For the CRISPR-Cas9 system to work, researchers have to design RNA sequences that specifically match the sequence of the target gene. CrispRGold, written by MDC scientists, helps to identify the most effective and specific RNA sequences. The team has also developed a mouse strain that expresses high levels of Cas9.
Community News from the Babraham Institute (BI), United Kingdom
The Babraham Institute’s ‘Ageing Cell’ conference took place earlier this year (27-28 March 2017) and was supported by the Biochemical Society among others. The event, which showcased the very latest research Ageing at a cellular level, brought together over 200 delegates to its campus and new conferencing facilities. In a programme designed to explore the intersections of research disciplines, the event did not disappoint.
Led by professor Ludo Van Den Bosch (VIB-KU Leuven), scientists from Belgium, the UK and the US have identified new processes that form protein “clumps” that are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). How these proteins, which can bind RNA in normal cells, stick together has long remained elusive.
Community News from the Centre for Genomic Regulation (CRG), Spain
EMBL and the Spanish government signed an agreement for a new site dedicated to tissue biology and disease modelling. EMBL and CRG will strengthen links further now that EMBL will be physically present on site and thanks to the establishment of the new CRG-EMBL Local Partnership until 2021.
News from the Instituto Gulbenkian de Ciência (IGC), Portugal
Dieting and exercise may not be sufficient to stay lean. Research performed in Ana Domingos’ laboratory at the IGC is deciphering the neurobiological mechanisms underlying obesity. Recently they showed that activation of sympathethic neurons in the adipose tissue burns fat, but their elimination triggers obesity.